Literature DB >> 18176183

Vincristine-induced peripheral neuropathy and urinary bladder paralysis in a child with rhabdomyosarcoma.

Elvan Caglar Citak1, Aynur Oguz, Ceyda Karadeniz, Belgin Karaoglan, Mustafa Ozgur Tan, Visal Okur, Ali Cansu.   

Abstract

Vincristine commonly induces peripheral neuropathy but rarely causes voiding dysfunction. In this report, we describe a case of neurogenic bladder and peripheral neuropathy caused by the neurotoxic effect of vincristine and documented by urodynamic testing and electromyography. Neurologic evaluation aided in monitoring and understanding this problem.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18176183     DOI: 10.1097/MPH.0b013e318158343b

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  4 in total

1.  Neuropathic pain during treatment for childhood acute lymphoblastic leukemia.

Authors:  Doralina L Anghelescu; Lane G Faughnan; Sima Jeha; Mary V Relling; Pamela S Hinds; John T Sandlund; Cheng Cheng; Deqing Pei; Gisele Hankins; Jennifer L Pauley; Ching-Hon Pui
Journal:  Pediatr Blood Cancer       Date:  2011-02-11       Impact factor: 3.167

2.  Doxorubicin induces detrusor smooth muscle impairments through myosin dysregulation, leading to a risk of lower urinary tract dysfunction.

Authors:  Nao Iguchi; M İrfan Dönmez; Alonso Carrasco; Duncan T Wilcox; Ricardo H Pineda; Anna P Malykhina; Nicholas G Cost
Journal:  Am J Physiol Renal Physiol       Date:  2019-05-08

3.  A prospective survey study of lower urinary tract dysfunction in childhood cancer survivors after vincristine and/or doxorubicin chemotherapy.

Authors:  Sarah L Hecht; Alan Quach; Dexiang Gao; Andrew Brazell; Gemma Beltran; Sheryl Holbrook; Lia Gore; Nao Iguchi; Anna Malykhina; Duncan Wilcox; Nicholas G Cost
Journal:  Pediatr Blood Cancer       Date:  2021-07-10       Impact factor: 3.838

4.  Sexual dimorphic impacts of systemic vincristine on lower urinary tract function.

Authors:  Nao Iguchi; Sarah L Hecht; Dexiang Gao; Duncan T Wilcox; Anna P Malykhina; Nicholas G Cost
Journal:  Sci Rep       Date:  2022-03-24       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.